FDA criticized at hearing about compounding pharmacies

11/14/2012 | Hill, The · Washington Post, The

The FDA needs new authority over drug compounders to avoid tragedies such as the fatal meningitis outbreak tied to contaminated custom-made drugs from the New England Compounding Center, FDA Commissioner Dr. Margaret Hamburg told members of a House Energy and Commerce subcommittee. However, several lawmakers sharply criticized the FDA, and committee Chairman Fred Upton, R-Mich., faulted the agency for not following up after finding problems years ago.

View Full Article in:

Hill, The · Washington Post, The